14 results

• Investigation Into CAR-T Cell Treatments Reveals New Data on Patient Deaths, Effectiveness

  December 13, 2023

  Katherine McDaniel

  A new study warns of a number of potential side effects and health risks linked to CAR-T drugs used to treat blood cancers like multiple myeloma,

• Multiple Myeloma Drug Side Effects Downplayed in Clinical Trials, Study Warns

  November 14, 2023

  Martha Garcia

  A new study warns that multiple myeloma drug clinical trials often downplay the severity of side effects and adverse results, Johns Hopkins researchers warn.

• Camp Lejeune Multiple Myeloma Lawsuit Filed By Son of Marine Stationed At Base in 1970s

  March 22, 2023

  Irvin Jackson

  The lawsuit blames Camp Lejeune water contamination for a U.S. Marine's son developing multiple myeloma.

• GSK Removes Blenrep From U.S. Market, Due Poor Clinical Trial Performance for Multiple Myeloma Drug

  November 23, 2022

  Irvin Jackson

  The multiple myeloma drug Blenrep is being removed from the U.S. market after the fast-tracked cancer drug failed to perform in a recent clinical trial.

• Zometa Side Effects Increase Risk of Osteonecrosis of the Jaw: Study

  January 14, 2021

  Irvin Jackson

  A new study suggests frequent Zometa injections increase the risk of jawbone death for some cancer patients.

• Venclexta Side Effects May Increase Risk Of Death In Multiple Myeloma Patients: FDA

  March 25, 2019

  Martha Garcia

  The FDA warns that clinical trials indicate Venclexta can increase the risk of death when given off-label to patients for the treatment of multiple myeloma.

• Homeowner Roundup Lawsuit Filed Over Multiple Myeloma Diagnosis

  August 23, 2018

  Irvin Jackson

  A Maine homeowner says he developed multiple myeloma after using Roundup to control weeds for years.

• Kyprolis Side Effects May Increase Risks of Heart Problems, Researchers Warn

  January 2, 2018

  Irvin Jackson

  A new study warns that Kyprolis heart problems may be more widespread than previously believed.

• Opdivo Multiple Myeloma Clinical Trials Halted Following Keytruda Deaths

  September 8, 2017

  Russell Maas

  After halting clinical trials involving the cancer drug Keytruda for treatment of multiple myeloma, the FDA has expanded the suspension to trials involving Opdivo, a similar medication.

• Keytruda Side Effects in Multiple Myeloma Combo Treatment Poses Serious Risks: FDA

  September 6, 2017

  Irvin Jackson

  Two clinical trials have been halted and the FDA is warning that Keytruda side effects may increase the risk of death when used with other drugs to treat multiple myeloma.